Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.

J Lacka; E Oravcova; L Sevcikova; M Studena; V Bachanova; E Kukuckova; S Spanik; J Sufliarsky; L Helpianska; J Trupl

doi:10.1159/000239434

Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.

Identifier:nobleid.org/w1/20260515/1F0BA2F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1F0BA2F3.svg?ark=w1%2F20260515%2F1F0BA2F3)](https://nobleid.org/work/w1/20260515/1F0BA2F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.

Identifier:nobleid.org/w1/20260515/1F0BA2F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1F0BA2F3.svg?ark=w1%2F20260515%2F1F0BA2F3)](https://nobleid.org/work/w1/20260515/1F0BA2F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work